Brokers Set Expectations for Cosmos Health Q3 Earnings

Cosmos Health Inc. (NASDAQ:COSM) – Stock analysts at Zacks Research cut their Q3 2026 EPS estimates for Cosmos Health in a report released on Wednesday, October 7th. Zacks Research analyst B. Sorensen now anticipates that the company will earn ($0.06) per share for the quarter, down from their previous estimate of ($0.05). The consensus estimate for Cosmos Health’s current full-year earnings is ($0.21) per share. Zacks Research also issued estimates for Cosmos Health’s Q4 2026 earnings at ($0.06) EPS and FY2026 earnings at ($0.22) EPS.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings data on Tuesday, August 18th. The company reported ($0.10) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.10). The company had revenue of $19.32 million for the quarter, compared to analysts’ expectations of $18.99 million. Cosmos Health had a negative net margin of 33.08% and a negative return on equity of 56.88%.

Separately, Weiss Ratings upgraded Cosmos Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Cosmos Health Price Performance

COSM stock opened at $0.38 on Wednesday. The stock’s 50 day simple moving average is $0.28 and its 200 day simple moving average is $0.28. Cosmos Health has a fifty-two week low of $0.16 and a fifty-two week high of $1.26. The company has a quick ratio of 0.92, a current ratio of 1.05 and a debt-to-equity ratio of 0.15.

Insider Activity at Cosmos Health

In related news, CEO Grigorios Siokas acquired 349,825 shares of the stock in a transaction dated Thursday, July 30th. The stock was purchased at an average cost of $0.20 per share, with a total value of $69,965.00. Following the completion of the purchase, the chief executive officer directly owned 14,597,917 shares in the company, valued at $2,919,583.40. This trade represents a 2.46% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 26.15% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Cosmos Health stock. BlackRock Inc. purchased a new position in shares of Cosmos Health Inc. (NASDAQ:COSM) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned approximately 0.45% of Cosmos Health at the end of the most recent quarter. Hedge funds and other institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc is a global healthcare group that develops, markets and distributes pharmaceutical, nutraceutical and wellness products. The company serves consumers, healthcare professionals and commercial partners through a portfolio that includes prescription and over-the-counter medicines, dietary supplements, vitamins and other health-related products.

Cosmos Health markets proprietary nutraceutical brands, including Sky Premium Life, and offers products across categories such as vitamins, minerals, sports nutrition and general wellness.